Eaton Vance Management’s LifePoint Health, Inc. LPNT Stock Holding History

Eaton Vance Management’s Portfolio LPNT Stock Details LPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-49,097	Closed	-$3.16M	–	1249
2018 Q3	$3.16M	Hold	49,097	–	–	0.01%	645
2018 Q2	$2.4M	Sell	49,097 -49,097	-50%	-$2.54M	0.01%	697
2018 Q1	$4.62M	Buy	98,194 +49,097	+100%	+$2.36M	0.01%	687
2017 Q4	$2.44M	Hold	49,097	–	–	0.01%	666
2017 Q3	$2.84M	Hold	49,097	–	–	0.01%	619
2017 Q2	$3.3M	Hold	49,097	–	–	0.01%	563
2017 Q1	$3.22M	Hold	49,097	–	–	0.01%	546
2016 Q4	$2.79M	Hold	49,097	–	–	0.01%	550
2016 Q3	$2.91M	Buy	49,097 +39,118	+392%	+$2.35M	0.01%	516
2016 Q2	$652K	Sell	9,979 -20,000	-67%	-$1.36M	﹤0.01%	771
2016 Q1	$2.08M	Hold	29,979	–	–	0.01%	546
2015 Q4	$2.2M	Hold	29,979	–	–	0.01%	548
2015 Q3	$2.13M	Buy	+29,979	New	+$2.43M	0.01%	538

Other funds holding LPNT

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Eaton Vance Management's LPNT Position: Q4 2018 in Review

Eaton Vance Management sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 49,097 shares — an estimated $3.16M sold.

Eaton Vance Management first reported a position in LPNT in Q3 2015 and held it in 13 quarters. The position peaked at $4.62M in Q1 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

Eaton Vance Management reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
Eaton Vance Management sold 49,097 LifePoint Health, Inc. shares in Q4 2018, an estimated $3.16M.
Eaton Vance Management first reported a position in LifePoint Health, Inc. in Q3 2015 and held it in 13 quarters.
Eaton Vance Management's LifePoint Health, Inc. position peaked at $4.62M in Q1 2018.
3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Eaton Vance Management's 13F filing for Q4 2018, filed 7 Feb 2019.